Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 10/20 | 0.55 |
| ▸ | MGAM | O43451 | 9/20 | 0.55 |
| ▸ | AMY1A | P0DUB6 | 9/20 | 0.55 |
| ▸ | SI | P14410 | 9/20 | 0.55 |
| ▸ | MGAM2 | Q2M2H8 | 9/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | F2 | P00734 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.55 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.53 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | F12 | P00748 | 4/20 | 0.50 |
| ▸ | MIF | P14174 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2490623 | 1.00 | MAPT (0.61) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL13559645 | 0.83 | MAPT (0.64) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL461244 | 0.81 | MAPT (0.74) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL461243 | 0.81 | MAPT (0.74) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL13518869 | 0.81 | GAA (0.57) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL3689328 | 0.80 | GAA (0.58) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL535054 | 0.78 | GAA (0.64) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL4250719 | 0.77 | GAA (0.68) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL706083 | 0.77 | MGAM (0.68) | MAPTNPSR1GAAMGAMAMY1A | |
| SCHEMBL463197 | 0.77 | MAPT (0.70) | MAPTNPSR1GAAMGAMAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | POINT LOMA NAZARENE UNIVERSITY | 2023-03-30 | — | — | US | claimed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | claimed |
| EP-2014797-A2 | Coating composition for interconnection part of electrode and plasma display panel including the same | Samsung SDI Co., Ltd. (KR) | 2009-01-14 | — | — | EP | claimed |
| US-20080303439-A1 | Coating composition for interconnection part of electrode and plasma display panel including the same | SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) | 2008-12-11 | — | — | US | claimed |
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | POINT LOMA NAZARENE UNIVERSITY | 2023-03-30 | — | — | US | disclosed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| US-20080303439-A1 | Coating composition for interconnection part of electrode and plasma display panel including the same | SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) | 2008-12-11 | — | — | US | disclosed |
| US-7351849-B2 | Process for producing optically active β-amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
| US-7351849-B2 | Process for producing optically active β-amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | LSS, REL, RPN1 | MAPT 4107/4885NPSR1 3483/4885GAA 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.